IDEAS home Printed from https://ideas.repec.org/a/epw/pharma/v3y2023i2id756.html

Assessment of Anti-seizure Property of Plumbago indica L. on Zebrafish Model

Author

Listed:
  • Rupsa Saha
  • Amrita Chakravorty
  • Amrita Kumari
  • Kunal Gupta
  • Nilanjan Sarkar
  • Mainak Chakraborty

Abstract

The purpose of the current experiment was to determine the anti-convulsant activity of methanolic extract of Plumbago indica L. In a 50 ml beaker 200 mg of the methanolic extract of Plumbago indica L. was dissolved in water containing the experimental zebrafish. After about 20 minutes the fish was administered with pentylenetetrazole (PTZ) (30 mg in 0.5 ml water) intraperitoneally (i.p) to induce seizure in it. The experimental zebrafish immersed in methanolic extract of Plumbago indica L. and administered with PTZ i.p showed clonic seizure-like activity within a few seconds of administering the PTZ. After about 15 minutes, the experimental zebrafish was found to swim normally i.e., short swim at the top of the tank with no seizure activity. The behavioral profile during 15 minutes of immersion into methanolic extract of Plumbago indica L. and then intraperitoneum (i.p) administration of PTZ was characterized by stages defined as scores: (0) short swim (top of the tank), (1) increased swimming activity, (2) burst swimming (left and right movements), (3) circular movements, (4) clonic seizure-like behavior, (5) fall to the bottom of the tank and tonic seizure-like behavior, (6) death. To attain all scores, zebrafish was exposed to anti-convulsants and administered with PTZ showed varying seizure profiles, severity, and latencies. The study's findings revealed that Plumbago indica L. has significant pharmacological properties. Methanolic extract of Plumbago indica L. has a notable CNS depressive and anti-convulsant effect.

Suggested Citation

  • Rupsa Saha & Amrita Chakravorty & Amrita Kumari & Kunal Gupta & Nilanjan Sarkar & Mainak Chakraborty, 2023. "Assessment of Anti-seizure Property of Plumbago indica L. on Zebrafish Model," European Journal of Pharmaceutical Research, European Open Science Publishing, vol. 3(2), pages 1-4, March.
  • Handle: RePEc:epw:pharma:v:3:y:2023:i:2:id:756
    DOI: 10.24018/ejpharma.2023.3.2.56
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/pharma/article/view/756
    File Function: Abstract page
    Download Restriction: no

    File URL: https://eu-opensci.org/index.php/pharma/article/download/756/310
    File Function: Full text
    Download Restriction: no

    File URL: https://libkey.io/10.24018/ejpharma.2023.3.2.56?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:pharma:v:3:y:2023:i:2:id:756. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/pharma .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.